MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • MDS Virtual Congress 2021

    Deep Brain Stimulation in Confirmed Genetic Dystonias: A Comprehensive Review

    H. Sarva, F. Rodriguez-Porcel, S. Barkan, E. Gatto, P. Garcia Ruiz (New York, USA)

    Objective: Review DBS benefit in genetically confirmed dystonias. Background: Deep brain stimulation (DBS) is an established option for genetic dystonias such as DYT-1. While literature…
  • MDS Virtual Congress 2021

    A real-life study of Medical Cannabis effect on adults with dystonia

    S. Anis, A. Faust-Socher, D. Sverdlov, N. Hezi, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To assess the effect of Medical Cannabis (MC) on patients with dystonia. Background: MC has been suggested to treat involuntary contractions of muscles in…
  • MDS Virtual Congress 2021

    Exploring Local Field Potential changes in Dystonic Camptocormia.

    M. Chua, C. Harrington, S. Stanslaski, M. Hayes, G. Cosgrove, T. Herrington (Boston, USA)

    Objective: To describe a novel technology for detection of local field potentials in bilateral GPi-DBS to identify local field potential biomarker changes in dystonic camptocormia.…
  • MDS Virtual Congress 2021

    Injections of incobotulinumtoxinA at intervals less than 10 weeks are effective and safe for cervical dystonia patients with inadequate benefit from standard injection intervals

    C. Comella, R. Hauser, S. Isaacson, D. Truong, O. Oguh, J. Hui, E. Molho, M. Brodsky, E. Furr-Stimming, G. Comes, M. Hast, D. Charles (New Philadelphia, USA)

    Objective: To compare efficacy and safety of two injection schedules of incobotulinumtoxinA for treating cervical dystonia (CD). Background: In clinical practice, some CD patients receiving…
  • MDS Virtual Congress 2021

    Precision Medicine in Neurodegeneration associated with Pantothenate kinase (PKAN) , its possible?

    J. Abril Jaramillo (Seville, Spain)

    Objective: The objective of this review is to open a discussion on the usefulness of the use of cell models derived from patients as a…
  • MDS Virtual Congress 2021

    Botulinum Toxin Injections For Movement Disorders During the COVID-19 Pandemic: A Single-Center Experience

    B. Dorfman, M. Velickovic, W. Tse (New York, USA)

    Objective: To report on patterns of patients presenting to our center for botulinum toxin injections during the height of the COVID-19 pandemic in New York…
  • MDS Virtual Congress 2021

    THE EFFECT OF A HOME BASED SENSORIMOTOR CONTROL EXERCISE PROGRAM FOR CERVICAL DYSTONIA PATIENTS UNDER TREATMENT WITH BOTULINUM TOXIN INJECTIONS: OBSERVATIONAL STUDY

    J. de Pauw, D. Crosiers, S. Girma, Y. de Borger, L. Gaspard, D. Smagghe, W. de Hertogh (Wilrijk, Belgium)

    Objective: To evaluate the effect of a home-based exercise program focusing on sensorimotor control additional to standard care in patients with idiopathic cervical dystonia (CD).…
  • MDS Virtual Congress 2021

    Cluster headache associated with secondary unilateral blepharospasm : A Case Report

    P. Dugani, A. Mehta, P. R, M. Javali, P. Acharya, R. Srinivasa (Bengaluru, India)

    Objective: We describe a case of a 31 year old lady with cluster headache associated with secondary unilateral spasm of left eyelid resulting in closure…
  • MDS Virtual Congress 2021

    Ultrasound-controlled percutaneous neuromodulation alleviates muscle activation in physiotherapy practice

    RV. Bubnov, L. Kalika (Kyiv, Ukraine)

    Objective: The aim was to evaluate efficacy and clinical relevance of percutaneous  NM to alleviate muscle activation in physiotherapy practice. Background: Muscle activation has a…
  • MDS Virtual Congress 2021

    A Double Blind, Placebo Controlled, Crossover Study of Incobotulinumtoxin-A in Musician’s Focal Hand Dystonia

    S. Frucht, A. Nmashie, MC. George, C. Wu, A. Pantelyat, E. Altenmüller, M. Chen, D. Feng, DM. Simpson (New York, USA)

    Objective: To determine the safety and efficacy of incobotulinumtoxin-A (BoNT) in musician’s dystonia. Background: Few published trials of BoNT in upper limb task-specific dystonia are…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley